Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02208336 : Electronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation Therapy
PhaseN/A
AgesMin: N/A Max: N/A
Eligibility
Inclusion Criteria:

- RETROSPECTIVE: All patients seen in Dr. Lesser's clinic who received concurrent
temozolomide and radiation therapy followed by adjuvant temozolomide for newly
diagnosed malignant gliomas from 01/01/07 through 03/31/2010 will be analyzed

- PROSPECTIVE: All patients seen in Dr. Lesser's clinic who receive concurrent
temozolomide and radiation therapy followed by adjuvant temozolomide for newly
diagnosed malignant gliomas during and after the construction of the system until the
end of the study

Exclusion Criteria:

- Patients participating in clinical trials or other deviations from non-standard
therapies that engender similar monitoring risk will be evaluated for this study on a
case by case basis
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02208336      |      Link to official Clinicaltrials.gov listing
Locations
Winston-Salem, North Carolina
Facility: Comprehensive Cancer Center of Wake Forest University
Investigator: Glenn J. Lesser
Contact: Glenn J. Lesser Phone: 336-716-9527
Click HERE to send email to this center




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740